Extract from the Register of European Patents

EP About this file: EP0902789

EP0902789 - ANDROSTENE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.11.2002
Database last updated on 01.04.2026
Most recent event   Tooltip29.11.2002No opposition filed within time limitpublished on 15.01.2003  [2003/03]
Applicant(s)For all designated states
Soft Drugs, Inc.
6219 S.W. 93rd Avenue
Gainesville, FL 32608 / US
[1999/12]
Inventor(s)01 / BODOR, Nicholas, S.
6219 S.W. 93rd Avenue
Gainesville, FL 32608 / US
[1999/12]
Representative(s)Hedley, Nicholas James Matthew, et al
Kilburn & Strode LLP
Lancon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [1999/12]Hedley, Nicholas James Matthew, et al
Stephenson Harwood One, St. Paul's Churchyard
London EC4M 8SH / GB
Application number, filing date97921345.101.05.1997
[1999/12]
WO1997US06812
Priority number, dateUS19960017102P09.05.1996         Original published format: US 17102 P
[1999/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9742214
Date:13.11.1997
Language:EN
[1997/49]
Type: A1 Application with search report 
No.:EP0902789
Date:24.03.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 13.11.1997 takes the place of the publication of the European patent application.
[1999/12]
Type: B1 Patent specification 
No.:EP0902789
Date:23.01.2002
Language:EN
[2002/04]
Search report(s)International search report - published on:US13.11.1997
(Supplementary) European search report - dispatched on:EP24.02.1999
ClassificationIPC:C07J3/00, A61K31/56
[1999/12]
CPC:
A61K31/56 (EP,US); A61P27/14 (EP); A61P29/00 (EP);
A61P37/00 (EP); C07J3/005 (EP,US); C07J31/006 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/12]
Extension statesAL09.12.1998
LT09.12.1998
LV09.12.1998
RO09.12.1998
SI09.12.1998
TitleGerman:ANDROSTEN-DERIVATE[1999/12]
English:ANDROSTENE DERIVATIVES[1999/12]
French:DERIVES DE L'ANDROSTENE[1999/12]
Entry into regional phase09.12.1998National basic fee paid 
09.12.1998Search fee paid 
09.12.1998Designation fee(s) paid 
09.12.1998Examination fee paid 
Examination procedure01.12.1997Request for preliminary examination filed
International Preliminary Examining Authority: US
09.12.1998Examination requested  [1999/12]
19.10.1999Despatch of communication of intention to grant (Approval: No)
25.10.2000Despatch of a communication from the examining division (Time limit: M02)
30.10.2000Despatch of communication of intention to grant (Approval: later approval)
30.10.2000Reply to a communication from the examining division
12.07.2001Communication of intention to grant the patent
08.10.2001Fee for grant paid
08.10.2001Fee for publishing/printing paid
Opposition(s)24.10.2002No opposition filed within time limit [2003/03]
Fees paidRenewal fee
31.05.1999Renewal fee patent year 03
15.05.2000Renewal fee patent year 04
14.05.2001Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A] JPS617291  
 [A] JPS617291  
 [A]   CHEMICAL ABSTRACTS, vol. 105, no. 17, 27 October 1986, Columbus, Ohio, US; abstract no. 153397, NITTA K ET AL: "Corticosteroids" page 726; column 1; XP002086577 [A] 1-17 * abstract *
 [A]   PATENT ABSTRACTS OF JAPAN vol. 010, no. 148 (C - 350) 29 May 1986 (1986-05-29) [A] 1-17 * abstract *
 [A]   DATABASE WPI Section Ch Week 8608, Derwent World Patents Index; Class B01, AN 86-052889, XP002086578 [A] 1-17 * abstract *
 [A]   UENO H ET AL: "Synthesis and evaluation of antiinflammatory activities of a series of corticosteroid 17.alpha.-esters containing a functional group", JOURNAL OF MEDICINAL CHEMISTRY., vol. 34, no. 8, August 1991 (1991-08-01), WASHINGTON US, pages 2468 - 2473, XP002086576 [A] 1-17 * page 2473, compound 13c * * page 2470, column 2, paragraph 3 * * page 2471, column 1, paragraph 3 *

DOI:   http://dx.doi.org/10.1021/jm00112a023
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.